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A retrospective clinicopathological study of 82 patients with invasive urothelial carcinoma treated with
radical cystectomy was performed. There were 62 men and 20 women, median age at operation was
68-years-old and the 5-year overall cancer-specific survival rate was 82.5%.
Univariate analyses demonstrated that female patients had poor prognosis, and that lymphovascular
invasion was a predictor of recurrence. Multivariate Cox regression analyses including age, grade, and
vascular invasion, showed that vascular invasion was an independent predictor of recurrence (HR＝4.46,
P＝0.008).
(Hinyokika Kiyo 55 : 665-669, 2009)

































10例（内 7例が BCG 膀胱内注入療法施行後），G2 Ta


























G1 対 G2・G3，INFα 対 INFβ，pT2 以下対 pT3 以
上，ly− 対 ly＋，v− 対 v＋ のいずれにおいても後者
のほうが有意に高年齢に分布していた (Fig. 1）．ま
た，追加抗癌剤治療の行われた症例は，INFα 対 INF







を認めた因子は ly− (85％) 対 ly＋ (44％) (P＝0.003)
と v− (89％) 対 v＋ (39％) (P＝0.00003) であった









Table 1. Patient characteristics
No. of patiens (men/women) 82 (62/20)
Median age at operation (year, range) 68 (43-88)
Patients with/without recurrence 14/58
Additional chemotherapy
















Lymphatic invasion ly0 53
ly1 20
ly2 6
Blood vessel invasion v0 55
v1 23
v2 1
Lymph node metastasis Absent 78
Present 4
泌55,11,01-1
Fig. 1. Patient’s age and pathological findings.






















Lymphatic invasion ly− 0.88
ly＋ 0.79 P＝0.097
blood vessel invasion v− 0.83
v＋ 0.85 P＝0.774
Lymph node metastasis Absent 0.83
Present 1.00 P＝0.503


























Lymphatic invasion ly− 0.85
ly＋ 0.44 P＝0.003
Blood vessel invasion v− 0.89
v＋ 0.39 P＝0.00003
Lymph node metastasis Absent 0.86
Present 1.00 P＝0.518
Table 4. Multivariate analyses of prognostic factors of invasive bladder tumor
Parameter
Disease specific mortality Recurrence
Hazard ratio 95％ CI P value AIC Hazard ratio 95％ CI P value AIC
Gender 0.42 0.09 to 1.93 0.264 0.63 0.13 to 3.20 0.567
Age at operation 1.05 0.98 to 1.14 0.205 1.13 1.02 to 1.28 0.018
Additional chemotherapy 0.57 0.12 to 2.38 0.444 0.44 0.06 to 2.19 0.323
Grade 2.09 0.51 to 12.49 0.332 4.48 0.66 to 94.89 0.139
INF 2.70 0.74 to 10.35 0.131 5.05 0.84 to 37.27 0.076
pT 0.92 0.48 to 1.75 0.787 0.72 0.33 to 1.50 0.375
ly 8.42 1.24 to 70.21 0.029 11.80 0.32 to 577.35 0.174
v 0.22 0.02 to 2.11 0.190 0.15 0.00 to 5.74 0.299
Lymph node metastasis 0.00 7.22 0.378 110.74 0.00 12.67 0.457 108.32
Gender 0.20 0.06 to 0.66 0.009
INF 2.31 0.91 to 5.64 0.076
ly 2.73 0.89 to 8.43 0.078 103.67
Age at operation 1.08 1.00 to 1.18 0.044
Grade 4.30 1.08 to 29.74 0.037
v 4.46 1.48 to 14.21 0.008 101.42
Gender 0.25 0.08 to 0.79 0.020 108.35
INF 2.56 1.17 to 5.75 0.019 108.29
ly 3.10 1.08 to 8.92 0.036 109.93
Age at operation 1.07 1.00 to 1.15 0.037 107.24
Grade 2.48 0.78 to 15.04 0.142 109.44
v 4.48 1.50 to 13.20 0.007 104.62
泌55,11,01-2
Fig. 2. Tumor-free survival (ly−/＋).
泌55,11,01-3
Fig. 3. Tumor-free survival (v−/＋).


















特異生存率への関与を検討すると，Log Rank test に
て，無再発生存率に対する静脈侵襲の有無のみで有意









































Table 5. Multivariate analyses of prognostic factors of invasive bladder tumor (without neo-adjuvant therapy :
pT1-pT4 N0)
Parameter
Disease specific mortality Recurrence
Hazard ratio 95％ CI P value P(Log Rank) Hazard ratio 95％ CI P value
P
(Log Rank)
Adjuvant chemotherapy 0.13 0.01 to 1.29 0.082 0.549 0.26 0.04 to 1.60 0.147 0.588
Grade 0.20 0.02 to 2.10 0.179 0.390 579,140.03 0.00 0.992 0.506
INF 4.43 1.12 to 17.61 0.034 0.146 2.29 0.53 to 9.92 0.268 0.423
pT 0.35 0.05 to 2.24 0.264 0.288 0.54 0.10 to 2.86 0.470 0.196
ly 41.36 2.06 to 832.53 0.015 0.398 1.29 0.14 to 12.18 0.822 0.311
v 0.07 0.00 to 1.44 0.084 0.467 8.67 0.42 to 179.17 0.162 0.017
Adjuvant chemotherapy 0.23 0.04 to 1.34 0.102
v 7.04 1.32 to 37.67 0.023
泌55,11,01-4
Fig. 4. Tumor-free survival (without neo-adjuvant
therapy : pT1-pT4 N0) (v−/＋).
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